The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Workforce
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Advocacy in a COVID-19 America

Advocacy in a COVID-19 America

June 15, 2020 • By Ellen M. Gravallese, MD

  • Tweet
  • Email
Print-Friendly Version / Save PDF
wan wei / shutterstock.com

wan wei / shutterstock.com

These are truly extraordinary times. The COVID-19 pandemic has affected the rheumatology community, both providers and patients, in many ways, and our advocacy efforts are now more important than ever to ensure policymakers hear us and help address the issues facing our community. As with so many things during this pandemic, we are reimagining advocacy and finding new ways to be effective in Washington, D.C.

You Might Also Like
  • AMA House of Delegates Meeting Postponed Due to COVID-19, Advocacy Efforts Continue
  • The ACR on Air Podcast’s COVID-19 Series
  • Capitol Hill Rheumatology Advocacy Goes Virtual
Explore This Issue
June 2020
Also By This Author
  • Leveraging the ACR’s RISE Registry for Research

Our dedicated professional staff and volunteers in D.C. have continued to advocate for us in a virtual environment without missing a beat. In addition, we needed to find a way for individual ACR/ARP members to bring their concerns and recommendations directly to federal lawmakers during the pandemic—without traveling to Capitol Hill. Each year for many years, the ACR has held two major fly-in events in D.C. to meet directly with decision makers on challenges that face our specialty. Many of you have joined us in our nation’s capital for these important visits through the years, and you know the value of direct contact from you, a constituent, sharing your experiences and recommendations with lawmakers. How could this be accomplished in this period when travel is severely limited or banned?

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

As it became clear that in-person visits to D.C. for our usual May Advocacy Leadership Conference would be impossible, the ACR organized its first-ever Virtual Hill Day, involving leaders on our board of directors, as well as committee chairs and volunteer members of the Government Affairs Committee (GAC), Committee on Rheumatologic Care (CORC), RheumPAC, the Insurance Subcommittee and the Affiliate Society Council. Live training webinars were held in place of the typical in-person training in preparation for the visits, and telephone meetings took the place of in-person visits to congressional offices on the Hill.

I am grateful to the nearly 80 ACR volunteer leaders who held 139 teleconference meetings with representatives, senators and staff in Hill offices on May 22 to discuss the difficulties we currently face in our field and to share their experiences during the COVID-19 pandemic. I want to thank the Government Affairs Committee for planning these impactful virtual visits, GAC Chair Blair Solow, MD, and our professional advocacy staff, who made all of this happen seamlessly. I also want to thank the many ACR/ARP members and patients who added their voices from home through our Legislative Action Center, the ACR’s online platform providing advocates the ability to directly email their lawmakers with policy messages. Each one of these touch points with legislators makes a difference and helps move our concerns to the forefront.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Pages: 1 2 3 | Single Page

Filed Under: Legislation & Advocacy, President's Perspective, Technology Tagged With: COVID-19, RheumPACIssue: June 2020

You Might Also Like:
  • AMA House of Delegates Meeting Postponed Due to COVID-19, Advocacy Efforts Continue
  • The ACR on Air Podcast’s COVID-19 Series
  • Capitol Hill Rheumatology Advocacy Goes Virtual
  • Advocacy During a Pandemic: An Update from the Government Affairs Committee

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.